Who founded PEEL Therapeutics?

PEEL Therapeutics was founded by Joshua Schiffman in 2015.

How much funding has PEEL Therapeutics raised?

PEEL Therapeutics has disclosed $9.3M raised across 1 round.

Where is PEEL Therapeutics headquartered?

PEEL Therapeutics is headquartered in Salt Lake City, US.

PEEL Therapeutics

Salt Lake City, US · Founded 2015 · Delaware corporation

Find your way into PEEL Therapeutics

266 people in our graph share verified history with the PEEL Therapeutics team — schools, employers, funds. One of them is your warm intro.

Karim Farisunlockedknows Joshua Schiffman · together at Brown University (overlapped)

knows the team · via Brown Medical School

×8knows the team · via Stanford University School of Medicine

knows the team · via University of Utah

knows the team · via Brown University

Peel Therapeutics is a clinical-stage biotech company developing evolutionary-inspired medicines for cancer and immune diseases, including elephant p53 (EP53) nanoparticles. It uses its Darwin.AI platform, evolutionary biology, and comparative genomics to identify novel drug targets and molecules found in nature.

AI & Machine Learning Biotech Healthtech

Founders & leadership

PEEL Therapeutics was founded in 2015 by Joshua Schiffman.

Joshua Schiffman inCEO and Co-FounderJoshua Schiffman is CEO and co-founder of PEEL Therapeutics, a clinical-stage biotech company developing evolution-inspired medicines for cancer and immune diseases. He is a pediatric hematologist-oncologist and professor at the University of Utah's Huntsman Cancer Institute, with medical degree from Brown University (2000) and clinical training at Stanford University, whose research focuses on cancer genomics and studying naturally cancer-resistant animals.

Avraham SchroederNamed on SEC filing

James LevisonNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$9.3M disclosed across 1 round · 2017

▶$9.3MraisedFeb 2019 · 70 investors · Biotechnology

Rule 506(c)

Officers, directors & promoters on the filing

Avraham SchroederDirector
Joshua SchiffmanExecutive Officer, Director
James LevisonExecutive Officer

Offering amount: $10M
Amount sold: $9.3M
First sale: Oct 2017
Incorporated: Corporation, Delaware, 2015
Federal exemptions: 06c

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Applied Therapeutics10 shared keywordsApplied Therapeutics is a biopharmaceutical company developing novel drugs for rare diseases with high unmet medical need. Its Aldose Reductase Inhibitor franchise is in development across disease areas including Galactosemia and SORD Deficiency.

Companies competing with PEEL Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does PEEL Therapeutics do?: Peel Therapeutics is a clinical-stage biotech company developing evolutionary-inspired medicines for cancer and immune diseases, including elephant p53 (EP53) nanoparticles. It uses its Darwin.AI platform, evolutionary biology, and comparative genomics to identify novel drug targets and molecules found in nature.
Who founded PEEL Therapeutics?: PEEL Therapeutics was founded by Joshua Schiffman in 2015.
How much funding has PEEL Therapeutics raised?: PEEL Therapeutics has disclosed $9.3M raised across 1 round.
Where is PEEL Therapeutics headquartered?: PEEL Therapeutics is headquartered in Salt Lake City, US.